APA (7th ed.) Citation

YS, W., LH, Q., CC, L., & KD, Y. (2026). Metabolic drivers of genome instability in cancer: Mechanisms and therapeutic opportunities. Experimental hematology & oncology, 15(1), . https://doi.org/10.1186/s40164-026-00775-3

Chicago Style (17th ed.) Citation

YS, Wang, Qian LH, Liu CC, and Yu KD. "Metabolic Drivers of Genome Instability in Cancer: Mechanisms and Therapeutic Opportunities." Experimental Hematology & Oncology 15, no. 1 (2026). https://doi.org/10.1186/s40164-026-00775-3.

MLA (9th ed.) Citation

YS, Wang, et al. "Metabolic Drivers of Genome Instability in Cancer: Mechanisms and Therapeutic Opportunities." Experimental Hematology & Oncology, vol. 15, no. 1, 2026, https://doi.org/10.1186/s40164-026-00775-3.